Loading Chart Rhythms
Preparing market rhythm analysis...
Preparing market rhythm analysis...
Full Rhythm Report
WAT • Stock • Health Care / Life Sciences Tools & Services
Executive Summary
Supportive setup, but not clean. WAT has a positive read, but risk signals need to stay controlled for the rhythm to remain strong.
Price Rhythm Chart
Live quote data is pending, so this chart is a visual placeholder until market data is available.
Strategy Scorecard
Daily Setup
Supportive
Swing Setup
Building
Long-Term Setup
Constructive
Confidence
High
Risk Level
Moderate
Today Strategy
Today’s setup is supportive. The latest articles are giving the stock a positive tone, with life sciences software demand, earnings expectations, and growth expectations acting as the main driver. The daily read stays useful only if fresh headlines keep supporting the same idea.
Swing Strategy
For the next few weeks to months, the swing setup depends on repetition. If life sciences software demand, earnings expectations, and growth expectations keeps appearing across new articles, the read strengthens. If the theme fades or risk language rises, the setup weakens.
Long-Term Strategy
For the long-term view, the system is watching whether Waters Corporation's bigger story remains durable. The current narrative is connected to life sciences software demand, earnings expectations, and growth expectations, but the long-term read still depends on valuation, competition, margins, execution, and whether future sources continue supporting the thesis.
These are the latest sources connected to this strategy report.
Source: MarketBeat • Published: 2026-08-15
Assetmark Inc. significantly reduced its stake in Waters Corporation (NYSE:WAT) by 56.5% in the second quarter, now holding 4,196 shares valued at $1.57 million. Other institutional investors like Zions Bancorporation and SHP Wealth Management have recently adjusted their positions in Waters, with institutional ownership standing at 94.01%. Insider activity also includes Director Christopher A. Kuebler selling 3,626 shares for over $1.4 million.
View original source →Source: MarketBeat • Published: 2026-08-14
Erste Asset Management GmbH reduced its stake in Waters Corporation by 27.1% in the second quarter, selling 3,078 shares and retaining 8,268 shares valued at $3.07 million. Waters Corporation exceeded quarterly expectations with $3.05 EPS and $1.65 billion in revenue, representing a 113.3% year-over-year revenue increase. The company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $420.35, and it has provided strong guidance for Q3 and full-year 2026 EPS.
View original source →Help improve this analysis
This feedback is saved locally for the MVP. Later, Chart Rhythms can use this feedback to improve the strategy engine.
Important:
Chart Rhythms provides source-based market summaries for research and informational purposes only. This is not financial advice and not a recommendation to buy, sell, or hold any security.
Source: Yahoo • Published: 2026-08-13
Waters Corporation’s Q2 results were met with a positive market reaction, driven by strong organic growth and momentum from its recently acquired Biosciences and Diagnostic Solutions businesses. Management pointed to robust demand across pharmaceutical, academic, and government markets, as well as the successful integration of new product launches. CEO Udit Batra highlighted that, "GLP-1 testing part of the business grew over 40% this quarter," with broad-based contributions across regions. The
Source: Stock Titan • Published: 2026-08-12
Waters Corporation reported a significant Q2 2026 net loss of $136 million, swinging from a net income of $147 million in the prior year, following its $12.96 billion acquisition of BD’s Biosciences and Diagnostic Solutions (BDS) business. Despite revenues more than doubling to $1.65 billion due to the acquisition, the loss was driven by substantial integration-related costs, including $244 million in purchased intangibles amortization, $49 million in restructuring charges, and increased interest expenses. The company also undertook a 3% workforce reduction to manage costs post-acquisition.
View original source →Source: Yahoo • Published: 2026-08-11
Organic growth accelerated to 9% as acquired units and legacy markets recovered.
View original source →Source: MarketBeat • Published: 2026-08-11
Dynamic Advisor Solutions LLC significantly reduced its stake in Waters Corporation (NYSE:WAT) by 85.3% in the second quarter of 2026, selling 8,431 shares and retaining 1,450 shares valued at $544,000. Waters Corporation recently reported strong quarterly earnings, beating analyst expectations with an EPS of $3.05 and revenue of $1.65 billion, and provided optimistic guidance for the third quarter and full year 2026. Analysts maintain a "Moderate Buy" consensus rating for Waters, with an average target price of $418.10.
View original source →Source: Investing.com • Published: 2026-08-11
Waters Corporation (WAT) stock reached a new 52-week high of $414.15, marking a 47.43% increase over the past year and a 25% gain in the last six months. Despite trading at a high P/E ratio of 185.8 and being considered overvalued by InvestingPro analysis, the company recently surpassed Q2 2026 earnings and revenue expectations. Additionally, TD Cowen upgraded Waters' stock to "Buy" with a raised price target of $475, citing expectations for continued high-single-digit growth.
View original source →Source: TradingView • Published: 2026-08-11
Waters Corp (WAT) reported its second-quarter 2026 results, showing a significant increase in revenue to $1.65 billion, primarily due to the acquisition of BDS. Despite the revenue growth, the company posted a net loss of $136 million and diluted earnings per share of $(1.39) for the quarter. Business highlights include strong recurring and consumables momentum, broad geographic expansion, and ongoing operational integration efforts including a workforce reduction.
View original source →